Test ID: VWD2N
von Willebrand Disease 2N (Subtype Normandy), Blood
Secondary ID 
A test code used for billing and in test definitions created prior to November 2011
81662
NY State Approved Indicates the status of NY State approval and if the test is orderable for NY State clients.
Yes
Useful For Suggests clinical disorders or settings where the test may be helpful
Diagnosis of von Willebrand disease (vWD) Type 2N
Evaluation and genetic counseling of patients with mild-to-moderate hemophilia A with an atypical inheritance pattern
Evaluation of hemophilia A patients with a shortened survival of infused factor VIII (FVIII) (not caused by a specific FVIII inhibitor)
Evaluation of female patients with low FVIII activity and no prior family history of hemophilia A
Evaluation of patients with Type 1 or Types 2A, 2B, or 2M vWD with FVIII activity discordantly lower than the von Willebrand factor antigen level
Special Instructions and Forms Describes specimen collection and preparation information, test algorithms, and other information pertinent to test. Also includes pertinent information and consent forms to be used when requesting a particular test
Method Name A short description of the method used to perform the test
Direct Mutation Analysis by Polymerase Chain Reaction (PCR)
(PCR is utilized pursuant to a license agreement with Roche Molecular Systems, Inc.)
Reporting Name A shorter/abbreviated version of the Published Name for a test; an abbreviated test name
von Willebrand Disease 2N (Normandy)
Aliases Lists additional common names for a test, as an aid in searching
Factor VIII binding defect
Normandy Subtype (von Willebrand Disease 2N)
Von Willebrand Disease 2N (Subtype Normandy)
VWD Type 2N
Normandy Subtype (von Willebrand Disease 2N)
Von Willebrand Disease 2N (Subtype Normandy)
VWD Type 2N
External
link
PDF
document
Excel
document
Word
document